Yüklüyor......
Abiraterone in the treatment of metastatic castration-resistant prostate cancer
Androgen deprivation therapy remains the single most effective treatment for the initial therapy of advanced prostate cancer, but is uniformly marked by progression to castration-resistant prostate cancer (CRPC). Residual tumor androgens and androgen axis activation are now recognized to play a prom...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3912049/ https://ncbi.nlm.nih.gov/pubmed/24501545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S39318 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|